You searched for lung cancer | Page 47 of 173

Thermo Fisher and Boehringer Ingelheim Sign CDx Agreement to Select NSCLC Patients for Targeted Therapy

Posted by Andy Lundin | Oct 19, 2023 | Lung Cancer |

Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients.

For Strata Oncology, clinical diagnostics is critical for the move to a precision medicine model. It’s doing so with its Strata Select test.

Posted by Andy Lundin | Oct 10, 2023 | Cancer |

The genomic profiling test is approved to identify patients with solid tumors with RET gene fusions who may benefit from Retevmo treatment.

Posted by Andy Lundin | Oct 10, 2023 | Lung Cancer |

DELFI’s blood test provides results by determining the likelihood of detecting lung cancer through low-dose CT, with an NPV of 99.7 percent.

Posted by Andy Lundin | Oct 9, 2023 | Lung Cancer |

Liquid biopsies may identify NSCLC patients undergoing immunotherapy who could benefit from treatment with additional drugs.